The expiration of a temporary federal Medicaid ban allows Planned Parenthood and similar clinics to once again receive reimbursements for routine healthcare services where states permit. Advocates say access has improved, but clinic closures, state restrictions and broader Medicaid cuts continue to threaten care.
Tag: KFF
Posted inWord In Black
A year in, No. 47’s spending cuts hit hardest in Black communities
A year later, a range of experts say predictions about how bad the One Big Beautiful Bill Act cuts are are coming true. The budget cuts are landing hardest on the low-income Americans who rely on them most — and hitting Black communities with extreme force.
Posted inOPINION
Protect our gains: Why the Black community must fight to save ACA subsidies
By Rev. Stacy Swimp The enhanced health insurance subsidies, set to expire at the end of 2025, represent a direct threat to the financial and health stability of Black Americans. While the crisis affects all races, the consequences for the Black community will be disproportionate and severe, effectively rolling back historic progress in health equity. […]
Posted inHealth
As ACA enhanced subsidy expiration looms, families brace for higher costs and limited care
With the expiration of the Affordable Care Act’s enhanced subsidies looming, families who rely on Medicaid coverage are facing uncertainty about how they will afford care. For parents like Hillary Harris in Missouri and Sam Gwesinie in Minnesota, higher costs and reduced access threaten both their own health and the care of their children.
Posted inNational News
Supreme Court rejects challenge to abortion pill mifepristone
The U.S. Supreme Court unanimously voted to dismiss a challenge to mifepristone, an abortion pill, and keep it on the market, while Democrats and advocates continue to fight for reproductive freedom.
Posted inWord In Black
Price of popular diabetes drugs denies low-income folks access to treatment
Supply shortages and insurance hurdles for GLP-1 agonists, such as Ozempic and Trulicity, have left many people with diabetes and obesity without the medicines they need to stay healthy, with drugmakers charging high prices and insurers imposing prior authorization requirements.
